Assignee
SYNTHEKINE INC
US·20 granted patents·29 pending applications·18 citations·filing 2020–2025
Top patents by PatentIndex Score
49 records- 0195US11873349B1Compositions and methods related to IL27 receptor bindingSYNTHEKINE INC·Filed 2023·Granted Jan 16, 2024·3 cites·6 claims
- 0294US12103954B2Heterodimeric Fc cytokines and uses thereofSYNTHEKINE INC·Filed 2024·Granted Oct 1, 2024·2 cites·15 claims
- 0393US11859001B2IL12RB1-Binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted Jan 2, 2024·2 cites·14 claims
- 0491US12077594B2IL2RG binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted Sep 3, 2024·3 cites·22 claims
- 0590US11491205B2Biased IL2 muteins methods and compositionsSYNTHEKINE INC·Filed 2021·Granted Nov 8, 2022·4 cites·18 claims
- 0688US12012457B1IL23R binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted Jun 18, 2024·1 cites·42 claims
- 0787US12291572B2IL12 receptor synthetic cytokines and methods of useSYNTHEKINE INC·Filed 2021·Granted May 6, 2025·1 cites·12 claims
- 0887US12157773B2IL27RAlpha binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted Dec 3, 2024·1 cites·53 claims
- 0986US12297281B2IL10RA binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted May 13, 2025·1 cites·16 claims
- 1079US12522639B2Heterodimeric FC cytokines and uses thereofSYNTHEKINE INC·Filed 2023·Granted Jan 13, 2026·0 cites·19 claims
- 1179US2025340656A1Compositions and methods related to receptor pairingsSYNTHEKINE INC·Filed 2025·Application pending·0 cites
- 1279US2025376528A1Compositions and methods related to receptor pairingsSYNTHEKINE INC·Filed 2025·Application pending·0 cites
- 1378US2024376217A1Il23r binding molecules and methods of useSYNTHEKINE INC·Filed 2024·Application pending·0 cites
- 1475US12440540B2IL-2 orthologs and methods of useSYNTHEKINE INC·Filed 2023·Granted Oct 14, 2025·0 cites·8 claims
- 1575US12209132B2Compositions and methods related to IL27 receptor bindingSYNTHEKINE INC·Filed 2023·Granted Jan 28, 2025·0 cites·19 claims
- 1675US2025019453A1Il2rb/il2g synthetic cytokinesSYNTHEKINE INC·Filed 2024·Application pending·0 cites
- 1775US2024166754A1Il12rb1-binding molecules and methods of useSYNTHEKINE INC·Filed 2023·Application pending·0 cites
- 1875US2025171548A1IL27RAlpha BINDING MOLECULES AND METHODS OF USESYNTHEKINE INC·Filed 2024·Application pending·0 cites
- 1975US2025163167A1Il10 receptor binding molecules and methods of useSYNTHEKINE INC·Filed 2024·Application pending·0 cites
- 2072US12139545B2IL10 receptor binding molecules and methods of useSYNTHEKINE INC·Filed 2023·Granted Nov 12, 2024·0 cites·15 claims
- 2171US12286482B2IL10RB binding molecules and encoding nucleic acidsSYNTHEKINE INC·Filed 2021·Granted Apr 29, 2025·0 cites·13 claims
- 2269US2024026014A1Compositions and methods related to receptor pairingsSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 2369US2025179198A1Compositions and methods related to il27 receptor bindingSYNTHEKINE INC·Filed 2024·Application pending·0 cites
- 2467US12018085B2Interferon-gamma R2 (IFNGR2) binding molecules comprising single-domain antibodies and method of use thereof to treat autoimmune and inflammatory diseasesSYNTHEKINE INC·Filed 2021·Granted Jun 25, 2024·0 cites·109 claims
- 2567US2025333521A1Il10rb binding molecules and encoding nucleic acidsSYNTHEKINE INC·Filed 2025·Application pending·0 cites
- 2664US2025042966A1Il10 variants and uses thereofSYNTHEKINE INC·Filed 2022·Application pending·0 cites
- 2763US2023272094A1Il2rb/il2rg synthetic cytokinesSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 2862US11648296B2IL-2 orthologs and methods of useSYNTHEKINE INC·Filed 2020·Granted May 16, 2023·0 cites·2 claims
- 2962US2023031597A1Biased il2 muteins methods and compositionsSYNTHEKINE INC·Filed 2022·Application pending·0 cites
- 3062US2025388640A1Human il-12p40 variants and uses thereofSYNTHEKINE INC·Filed 2022·Application pending·0 cites
- 3159US12448457B2GP130 binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted Oct 21, 2025·0 cites·20 claims
- 3259US2023279126A1Il23 receptor synthetic cytokines and methods of useSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 3359US2023279125A1Il28ra binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 3459US2023391891A1Il28a receptor binding synthetic cytokines and methods of useSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 3559US2025382382A1Orthogonal gpc3 chimeric antigen receptor t cellsSYNTHEKINE INC·Filed 2023·Application pending·0 cites
- 3659US2023365696A1Ifngr1 binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 3758US2025333520A1Compositions and methods related to il2 receptor bindingSYNTHEKINE INC·Filed 2022·Application pending·0 cites
- 3858US2025288666A1Methods and compositions for use in cell therapy of neoplastic diseaseSYNTHEKINE INC·Filed 2022·Application pending·0 cites
- 3958US2023357414A1Il12rb2 binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 4056US12122839B2IFNGR binding synthetic cytokines and methods of useSYNTHEKINE INC·Filed 2021·Granted Oct 22, 2024·0 cites·14 claims
- 4156US2023357424A1Cd45 binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 4255US12234291B2IL2RB binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted Feb 25, 2025·0 cites·37 claims
- 4354US2025163162A1Compositions and methods related to receptor pairingSYNTHEKINE INC·Filed 2022·Application pending·0 cites
- 4453US12540188B2IL10Rα/IL2Rγ synthetic cytokinesSYNTHEKINE INC·Filed 2021·Granted Feb 3, 2026·0 cites·14 claims
- 4551US2023374454A1Human immune cells genomically modified to express orthogonal receptorsSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 4650US2023027899A1Cd122 with altered icd stat signalingSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 4749US2023076768A1IL2 Orthologs and Methods of UseSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 4848US2023159892A1Engineered immune cellsSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 4946US2023210951A1Il2 muteinsSYNTHEKINE INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →